Search

Your search keyword '"Cupelli, L."' showing total 10 results
Start Over Author "Cupelli, L." Publisher springer verlag
10 results on '"Cupelli, L."'

1. Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.

Author

Niscola P, Tendas A, Abruzzese E, Caravita T, Cupelli L, Giovannini M, Scaramucci L, Siniscalchi A, Trawinska MM, and de Fabritiis P

Subjects
Aged, Disease Management, Female, Follow-Up Studies, Frail Elderly, Humans, Male, Middle Aged, Retrospective Studies, Survival Analysis, Treatment Outcome, Antimetabolites, Antineoplastic therapeutic use, Azacitidine therapeutic use, Leukemia, Myelomonocytic, Chronic drug therapy
Published
2017
Full Text
View/download PDF

2. Bone marrow aspiration and biopsy-related pain management.

Author

Sollazzo F, Tendas A, Conte E, Bianchi MP, Niscola P, Cupelli L, Mauroni MR, Molinari V, D'Apolito A, Pilozzi V, Cacciaraichi S, Viggiani C, Pignatelli AC, Annibali O, Mengarelli A, Dentamaro T, de Fabritiis P, Ferrari A, Montefusco E, and Arcese W

Subjects
Humans, Biopsy, Needle adverse effects, Bone Marrow Examination adverse effects, Pain prevention & control, Pain Management methods
Published
2014
Full Text
View/download PDF

3. Epidemiology and pathogenesis of incident pain-related disability in malignant hematology: an Italian survey.

Author

Tendas A, Niscola P, Giovannini M, Scaramucci L, Cupelli L, Dentamaro T, and de Fabritiis P

Subjects
Activities of Daily Living, Adult, Aged, Data Collection, Disease Progression, Hematologic Neoplasms pathology, Humans, Incidence, Italy epidemiology, Middle Aged, Pain complications, Disabled Persons statistics & numerical data, Hematologic Neoplasms complications, Hematologic Neoplasms epidemiology, Pain epidemiology, Pain etiology
Published
2011
Full Text
View/download PDF

4. Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience.

Author

Caravita T, Siniscalchi A, Tendas A, Cupelli L, Ales M, Perrotti A, Niscola P, and de Fabritiis P

Subjects
Aged, Antineoplastic Combined Chemotherapy Protocols adverse effects, Dexamethasone adverse effects, Doxorubicin adverse effects, Drug Resistance, Neoplasm drug effects, Female, Follow-Up Studies, Humans, Lenalidomide, Male, Middle Aged, Multiple Myeloma mortality, Recurrence, Thalidomide administration & dosage, Thalidomide adverse effects, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Dexamethasone administration & dosage, Doxorubicin administration & dosage, Multiple Myeloma drug therapy, Thalidomide analogs & derivatives
Published
2011
Full Text
View/download PDF

5. Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA).

Author

Tendas A, Niscola P, Dentamaro T, Cupelli L, Di Matteo G, Finocchi A, Siniscalchi A, Fratoni S, Scimò T, Scaramucci L, Giovannini M, Ales M, Pio Perrotti A, and de Fabritiis P

Subjects
Abdomen, Acute complications, Abdomen, Acute diagnosis, Adult, Agammaglobulinemia complications, Cholecystitis complications, Cholecystitis diagnosis, Diagnosis, Differential, Genetic Diseases, X-Linked complications, Humans, Male, Pancytopenia complications, Sepsis complications, Agammaglobulinemia diagnosis, Genetic Diseases, X-Linked diagnosis, Pancytopenia diagnosis, Sepsis diagnosis
Published
2010
Full Text
View/download PDF

6. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.

Author

Niscola P, Palumbo R, Scaramucci L, Tendas A, Cupelli L, Giovannini M, Piccioni D, Dentamaro T, Perrotti AP, and de Fabritiis P

Subjects
Aged, Antibodies, Monoclonal, Murine-Derived, Female, Humans, Lymphoma, B-Cell, Marginal Zone complications, Renal Dialysis, Rituximab, Splenic Neoplasms complications, Antibodies, Monoclonal therapeutic use, Antineoplastic Agents therapeutic use, Lymphocytes drug effects, Lymphoma, B-Cell, Marginal Zone drug therapy, Splenic Neoplasms drug therapy
Published
2009
Full Text
View/download PDF

7. Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma.

Author

Tendas A, Cupelli L, Dentamaro T, Scaramucci L, Palumbo R, Niscola P, Giovannini M, Piccioni D, Perrotti AP, and de Fabritiis P

Subjects
Aged, Combined Modality Therapy methods, Drug Therapy, Combination, Humans, Lymphoma, Mantle-Cell drug therapy, Male, Vidarabine administration & dosage, Hematopoietic Stem Cell Transplantation methods, Lymphoma, Mantle-Cell surgery, Melphalan administration & dosage, Renal Dialysis, Transplantation Conditioning methods, Vidarabine analogs & derivatives
Published
2009
Full Text
View/download PDF

8. Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin's lymphoma patients.

Author

Perrotti AP, Niscola P, Tendas A, Scaramucci L, Palombi M, Cupelli L, Dentamaro T, Piccioni D, Giovannini M, and de Fabritis P

Subjects
Adult, Aged, Aged, 80 and over, Antineoplastic Agents therapeutic use, Deoxycytidine therapeutic use, Humans, Lymphoma, Non-Hodgkin mortality, Lymphoma, Non-Hodgkin pathology, Middle Aged, Prognosis, Treatment Failure, Treatment Outcome, Vinblastine therapeutic use, Vinorelbine, Gemcitabine, Deoxycytidine analogs & derivatives, Lymphoma, Non-Hodgkin drug therapy, Salvage Therapy methods, Vinblastine analogs & derivatives
Published
2008
Full Text
View/download PDF

9. Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report.

Author

Niscola P, Scaramucci L, Perrotti A, Fratoni S, Piccioni D, Tendas A, Cupelli L, Dentamaro T, Del Poeta G, and de Fabritiis P

Subjects
Anemia, Hemolytic, Autoimmune pathology, Anemia, Hemolytic, Autoimmune therapy, Fatal Outcome, Humans, Ileal Neoplasms pathology, Ileal Neoplasms secondary, Ileal Neoplasms therapy, Male, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma pathology, Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy, Anemia, Hemolytic, Autoimmune etiology, Ileal Neoplasms complications, Precursor Cell Lymphoblastic Leukemia-Lymphoma complications
Published
2008
Full Text
View/download PDF

10. Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey.

Author

Niscola P, Cartoni C, Romani C, Brunetti GA, D'Elia GM, Cupelli L, Tendas A, de Fabritiis P, Mandelli F, and Foà R

Subjects
Adolescent, Adult, Aged, Aged, 80 and over, Analgesics therapeutic use, Child, Child, Preschool, Data Collection, Female, Hematologic Neoplasms drug therapy, Hematologic Neoplasms epidemiology, Home Care Services, Humans, Italy epidemiology, Male, Middle Aged, Pain diagnosis, Pain Management, Pain Measurement, Treatment Outcome, Hematologic Neoplasms complications, Pain epidemiology, Pain etiology
Abstract

We report on epidemiology, features, outcome, and domiciliary management of pain in patients with advanced hematological malignancies followed by an experienced hospital-based home care (HC) team. Out of 469 patients, 244 (52%) experienced a total of 284 pain syndromes. Pain intensity was rated from mild to moderate in 31% and from moderate to severe in 69% of them. The diagnosed pain mechanisms were deep somatic in 56%, superficial somatic in 15%, visceral 14%, mixed 8%, and neuropathic in 7% of pain syndromes, respectively. Incident pain was observed in 38% of all pain syndromes. In every diagnostic group, deep somatic pain was prevalent. Moreover, 85% of visceral pain syndromes were observed in patients affected by non-Hodgkin's lymphoma (NHL). In addition, out of 284 pain syndromes, 150 (51%) were caused by bone involvement. The most frequent recognized pain provocative mechanisms were bone marrow expansions, osteolysis, lymph node enlargement, and mucositis. In our experience, an approach based on the association of causal therapies and analgesics allows optimal control of most pain syndromes. Therefore, pain is a major problem in patients affected by advanced hematological malignancies, and its management can be effective and feasible when carried out by a skilled HC team.

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results